Bank of America Raises AbbVie (NYSE:ABBV) Price Target to $223.00
AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by equities research analysts at Bank of America from $200.00 to $223.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Bank of America‘s price objective suggests a potential upside of 5.38% from the stock’s previous […]
AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by equities research analysts at Bank of America from $200.00 to $223.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Bank of America‘s price objective suggests a potential upside of 5.38% from the stock’s previous […]
